Skip to content
Recall Observatory FDA recall evidence

Drug product

Medroxyprogesterone Acetate Injectable Suspension, USP, 150 mg / mL, 1 mL Single-Dose Vial, Rx only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520, NDC 55150-0330-01

D-0400-2025

April 25, 2025

Class II

Product summary

Firm
Mckesson Medical-Surgical Inc. Corporate Office
Event
Event 96744
Status
Ongoing
Classification
Class II
Quantity
3
Official record key
drug-enforcement:D-0400-2025

Official wording

Reason: Severe thunderstorms caused transit delays of certain cold chain products that were shipped on 02-Apr-2025 and delivered after the 48-hours specified delivery time, on 07-Apr-2025 and 08-Apr-2025. The affected products may not have been stored at the recommended labeled storage conditions which may have impacted the safety, quality, identity, potency and purity of the product.

Code information: Lot #: 1MP24042, Exp 6/30/26

Distribution pattern: Distributed to Medical Facilities in MS and FL.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Severe thunderstorms caused transit delays of certain cold chain products that were shipped on 02-Apr-2025 and delivered after the 48-hours specified delivery time, on 07-Apr-2025 and 08-Apr-2025. The affected products may not have been stored at the recommended labeled storage conditions which may have impacted the safety, quality, identity, potency and purity of the product.

Field note

Send feedback

We'll only use this to respond to your feedback.